Morinaga Nutritional Foods launches Bifidobacterium breve MCC1274 in the U.S. - a clinically backed probiotic shown to support memory, attention, and brain health. Now available for B2B licensing and product development.
TORRANCE, Calif., Oct. 17, 2025 /PRNewswire-PRWeb/ -- Morinaga Nutritional Foods Launches Bifidobacterium breve MCC1274: A Clinically Validated Probiotic Targeting Cognitive Health
Morinaga Nutritional Foods, the U.S. subsidiary of one of Japan's largest and most respected dairy and nutritional ingredient companies, is proud to announce the commercial availability of B. breve MCC1274, a patented probiotic strain clinically shown to support cognitive function and brain health.
In a world where memory and mental sharpness are top wellness priorities, MCC1274 enters the market backed by rigorous human clinical trials, neuroimaging data, and mechanistic research. This cutting-edge probiotic strain is derived from Human-Residential Bifidobacteria (HRB) and developed specifically to meet the demands of consumers seeking non-pharmaceutical cognitive support as they age.
"The science behind MCC1274 is nothing short of remarkable," said Dominique Ostrander, General Manager of Morinaga Nutritional Foods. "With the rise of mild cognitive impairment and the consumer shift toward proactive brain health, MCC1274 delivers an unprecedented combination of clinical validation, safety, and scalability."
Clinically Proven Brain Support
MCC1274 has been shown in peer-reviewed clinical studies to:
- Improve memory, attention, and executive function
- Reduce hippocampal atrophy in neuroimaging scans
- Support cognitive performance in adults with mild cognitive impairment (MCI)
Unlike many cognitive supplements on the market, MCC1274's benefits are rooted in gut-brain axis research and reinforced by preclinical models showing reduced inflammation and neuronal protection.
Global Innovation, Local Execution
Already recognized in Japan and parts of Asia for its cognitive benefits, MCC1274 is now available for B2B licensing, formulation into finished products, and branded supplement development in the U.S. and other global markets.
To learn more about MCC1274 or to discuss distribution and partnership opportunities, please contact:
About Morinaga Nutritional Foods, Inc.
Morinaga Nutritional Foods is the U.S. subsidiary of Morinaga Milk Industry Co., Ltd., one of Japan's largest dairy and functional ingredient companies with over 100 years of innovation. A global leader in Human-Residential Bifidobacteria (HRB), Morinaga specializes in clinically researched probiotic strains for cognitive, digestive, immune, and metabolic health. The company is committed to developing scientifically validated, safe, and effective solutions that enhance wellness throughout every stage of life.
Media Contact
Dominique Ostrander, Morinaga Nutritional Foods, Inc., 1 813767.770, [email protected], https://morinagaprobiotics-usa.com/
SOURCE Morinaga Nutritional Foods, Inc.
Share this article